Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease, Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2005 |
| End Date: | May 2013 |
Post-licensure Safety Surveillance Study of Routine Use of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra ™)
To further characterize the safety profile of Menactra vaccine and to identify any signals
of potentially vaccine-related adverse events (AEs) not detected during pre-licensure
studies.
of potentially vaccine-related adverse events (AEs) not detected during pre-licensure
studies.
Inclusion Criteria:
- Receipt of Menactra vaccine during the study period.
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
